NDAQ Nasdaq Inc.

Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Bra

Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival; Nubia Brand International Corp.; The Alkaline Water Company Inc.; DMK Pharmaceuticals Corporation; MedAvail Holdings, Inc.; InVivo Therapeutics Holdings Corp.; and ADDvantage Technologies Group, Inc. from The Nasdaq Stock Market

NEW YORK,, March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc. Latch, Inc.’s securities were suspended on August 10, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Eloxx Pharmaceuticals, Inc. Eloxx Pharmaceuticals, Inc.’s securities were suspended on October 16, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants of Collective Audience, Inc. Collective Audience, Inc.’s warrants were suspended on November 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrants of SeqLL Inc. SeqLL Inc.’s securities were suspended on November 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Nemaura Medical Inc. Nemaura Medical Inc.’s securities were suspended on January 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock and warrant of LumiraDx Limited. LumiraDx Limited’s securities were suspended on January 9, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Series 1 Preferred Stock of Cemtrex Inc. Cemtrex Inc.’s shares of Series 1 Preferred Stock were suspended on January 22, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the perpetual preferred stock, common stock, and warrants of COMSovereign Holding Corp. COMSovereign Holding Corp.’s shares of perpetual preferred stock were suspended on January 23, 2024; the company’s shares of common stock and warrants were suspended on January 31, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock, units, and warrants of Global System Dynamics. Global System Dynamics’s securities were suspended on January 24, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of Arrival. Arrival’s securities were suspended on January 30, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrant of Nubia Brand International Corp. Nubia Brand International Corp.’s securities were suspended on February 5, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of The Alkaline Water Company Inc. The Alkaline Water Company Inc.’s securities were suspended on February 6, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of DMK Pharmaceuticals Corporation. DMK Pharmaceuticals Corporation’s securities were suspended on February 7, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of MedAvail Holdings, Inc. MedAvail Holdings, Inc.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of ADDvantage Technologies Group, Inc. ADDvantage Technologies Group, Inc.’s securities were suspended on February 13, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at  Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .



EN
20/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nasdaq Inc.

 PRESS RELEASE

Nasdaq Executives to Present at Upcoming Investor Conferences

Nasdaq Executives to Present at Upcoming Investor Conferences NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in March with webcasts available at Nasdaq’s Investor Relations website: . Who:Sarah Youngwood, Executive Vice President & Chief Financial Officer, NasdaqWhat:Morgan Stanley Technology, Media & Telecom ConferenceWhen:Monday, March 2nd, 11:30 AM ET  Who:Jeremy Skule, Executive Vice President, Chief Strategy Officer & Executive Chair, Financial Crime Management Technology, NasdaqWhat:Raymond James 47thAnnual Instituti...

 PRESS RELEASE

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Sto...

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 13, 2026 NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 13, 2026, short interest in 3,595 Nasdaq Global MarketSM securities totaled 15,834,216,597 shares compared with 15,574,683,465 shares in 3,547 Global Market issues reported for the prior settlement date of January 30, 2026. The mid-January short interest represents 2.25 days compared with 2.58 days for the prior reporting period. Short interest in 1,654 securities on The Nasdaq Capital M...

 PRESS RELEASE

Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for It...

Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for Its Next Phase of Scalable Growth at 2026 Investor Day Nasdaq raises medium-term Solutions revenue outlook to 9-12% growthMaintains medium-term outlook for expense growth of 5-8%Company reinforces its position as trusted transformation partner in the AI eraCommits to actioning AI productivity program with an expense efficiency target of $100 million by 2027 NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today will host its Investor Day at 8:00 a.m. ET, where Adena Friedman, Nasdaq Chair and CEO, Sarah ...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Nasdaq, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 18 February 2026 in which we reassessed the appropriateness of the ratings in the context of t...

 PRESS RELEASE

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq ...

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 30, 2026 NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 30, 2026, short interest in 3,547 Nasdaq Global MarketSM securities totaled 15,574,683,465 shares compared with 15,349,969,813 shares in 3,515 Global Market issues reported for the prior settlement date of January 15, 2026. The January short interest represents 2.58 days compared with 2.88 days for the prior reporting period. Short interest in 1,666 securities on The Nasdaq Capital Mark...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch